ESC 365 - Cohort Study of Serious Adverse Events with Sodium-Glucose Cotransporter 2 Inhibitors

ESC Premium Access

Cohort Study of Serious Adverse Events with Sodium-Glucose Cotransporter 2 Inhibitors

Session: Late Breaking Pharmacological Science

Topic: Antidiabetic Pharmacotherapy

Speaker: Doctor P. Ueda (Stockholm, SE)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Peter Ueda

Karolinska Institute, Stockholm (Sweden)

2 presentations

1 follower

12 more presentations in this session

Panel discussants.

CLARIFY - First-line anti-ischemic agents use and long-term clinical outcomes in stable coronary artery disease

Speaker: Doctor E. Sorbets (Paris, FR)

Panel discussion.

FOURIER - Efficacy of PCSK9 inhibition with evolocumab in patients with Metabolic Syndrome

Speaker: Professor P. Deedwania (Fresno, US)

Panel discussion.

Access the full session

Late Breaking Pharmacological Science

Speakers: Doctor P. Ueda, Doctor E. Sorbets, Professor P. Deedwania

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources